Ovarian aging sets the biological clock for female fertility and hormonal health, yet its molecular drivers have remained poorly understood. A mechanistic explanation now points directly at mitochondrial dysfunction…
For the estimated 50,000 people worldwide living with transthyretin amyloidosis — a progressive, often fatal disease…
For decades, cardiovascular risk was calculated in silos — blood pressure managed separately from cholesterol…
For the roughly 10–20% of rheumatoid arthritis patients who exhaust multiple biologic and targeted therapies without…
For the roughly half of adults over 30 living with significant periodontal disease, the standard clinical dilemma has…
A man in his mid-30s with longstanding type 1 diabetes self-administered an online-sourced product marketed as…
Among 491 surgical patients aged ≥65 undergoing elective laminectomy or joint replacement, 10% developed postoperative…
For the millions of adults who develop chest pain after viral illness — or after mRNA vaccination — the clinical…
For the millions of high-risk cardiovascular patients who fail to reach guideline-recommended LDL cholesterol targets…
The relationship between humans and their companion animals has long been studied for its psychological and…
The holy grail of antithrombotic therapy has long been separating clot prevention from bleeding risk — a trade-off…
For millions of adults living with cardiovascular disease, the question of how aggressively to suppress platelet…
For the millions of heart attack patients who arrive with blockages in multiple coronary arteries, the question of how…
For the millions of adults living with heart failure complicated by pulmonary hypertension, therapeutic options have…
Distinguishing heart failure subtypes quickly has real consequences: patients with reduced ejection fraction respond…
Among 7,671 UK Biobank participants with type 2 diabetes (mean age ~60), NMR-based metabolomic profiling across…
While global stroke and ischemic heart disease (IHD) mortality dropped 51.7% and 38.2% respectively between 1990 and…
A national digital recruitment campaign for the Phase 3 LIBREXIA-AF atrial fibrillation trial spent $163,949 across…
A benchtop NMR spectrometer operating at 80 MHz — far less powerful than laboratory-grade 600 MHz instruments…
A 65-week, 12-ward stepped-wedge cluster randomised controlled trial across five Australian hospitals will test…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.